Telaglenastat for treating pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests an investigational pill (called telaglenastat) to see if it can help people with pulmonary hypertension (high blood pressure in the lungs). Researchers want to learn if this drug improves symptoms like shortness of breath and exercise ability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 75 years
- Diagnosed with Group 1, Group 2 (with preserved heart function), or Group 3 pulmonary hypertension
- Symptoms in WHO functional class II or III (e.g. shortness of breath with mild activity)
- Able to walk at least 100 meters (about the length of a football field) in 6 minutes, but no more than 550 meters
- Taking stable heart or PH medications for at least 30 days (or 3 months for some Group 1 patients)
- Not have certain other conditions like significant heart valve disease, untreated sleep apnea, or recent blood clots
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if pioglitazone, a medicine used for diabetes, can help people with high blood pressure in their lungs caused by chronic lung disease. The goal is to see if it improves how your cells use energy.
This study tests an investigational drug (HS235) for people who have both heart failure with preserved ejection fraction and a type of pulmonary hypertension that can happen with it. The goal is to see if the drug can improve symptoms and quality of life.
This trial tests whether an inhaled medication called treprostinil (which helps open blood vessels in the lungs) can improve exercise ability in people who get high blood pressure in the lungs only during exercise. Participation involves taking the medication and doing exercise tests to see how well you do.
This study tests new “trial tools” and designs for running early research in people with pulmonary hypertension. If you qualify, you may be asked to do extra trial-related procedures to help researchers test the process safely and smoothly.
This study tests an investigational drug called sotatercept for people who have a specific type of high blood pressure in the lungs that happens along with heart failure with preserved ejection fraction (a stiff heart muscle). The treatment aims to improve your ability to be active and reduce symptoms, and the study will compare it to a placebo to see if it helps.
This trial tests an inhaled medicine that may help people with lung scarring or connective tissue disease who have high blood pressure in the lungs only during exercise. It aims to improve their ability to be active and reduce symptoms.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.